Otsuka Pharmaceuticals is collaborating with Health Innovation Oxford HIN to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support the treatment of major depressive disorder (MDD).
Otsuka and Oxford HIN collaborate to gather insights into digital therapeutics for mental health
